Canadian International School will host the 11th edition of its Juniors Golf Tournament for students. Choose from any one of ...
Platform now available to pharmaceutical research partners; powers collaborations totaling over $200 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery ...
Morning Overview on MSNOpinion
The quantum boom is near and a new industry is taking off
The quantum sector is shifting from speculative science to a commercial race, with hardware, software, and investment ...
Samsung Electronics today unveiled its “Companion to AI Living” vision at The First Look, its CES® 2026 event held in the ...
Learning speed and capital access are now decisive for homebuilders as operational and demand risks intensify in 2026.
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback